HIV

Janssen's latest Prezcobix effort taps HIV activists to curate patient-story contest
Fierce Pharma Marketing
Mon, 09/21/15 - 10:52 am
Janssen
JNJ
patients
HIV
Prezcobix
2 new studies show Gilead's Truvada extremely effective for HIV prevention
BioPharma Dive
Mon, 09/14/15 - 12:08 pm
Gilead Sciences
Truvada
HIV
Gilead combo HIV pill matches Truvada efficacy but safer in trial
Yahoo/Reuters
Wed, 09/2/15 - 10:20 am
Gilead Sciences
HIV
Truvada
clinical trials
F/TAF
Janssen's new Prezcobix push urges HIV patients to share pics with their docs
Fierce Pharma Marketing
Mon, 08/24/15 - 05:22 pm
JNJ
HIV
Janssen
Prezcobix
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
Seeking Alpha
Wed, 08/19/15 - 09:17 pm
GSK
ViiV Healthcare
Gilead
Pfizer
Bristol-Myers Squibb
HIV
BMS nabs EU approval for once-daily HIV combo pill
BioPharma Dive
Sat, 07/18/15 - 10:31 am
Bristol-Myers Squibb
Europe
HIV
Evotaz
What Glaxo's strategy guru thinks the future holds for HIV markets
BioPharma Dive
Fri, 07/10/15 - 12:30 pm
GSK
HIV
R&D
Success at Glaxo's HIV Unit May Mean Having to Call It Quits
Yahoo/Bloomberg
Thu, 07/9/15 - 10:23 am
GSK
HIV
ViiV Healthcare
Gilead Sciences Spent $125 Million to Get This Drug on the Market 4 Months Early
Motley Fool
Mon, 07/6/15 - 04:28 pm
Gilead Sciences
R/F/TAF
HIV
J&J vaccine completely prevented HIV in half of monkeys in trial
Yahoo/Reuters
Fri, 07/3/15 - 11:07 am
JNJ
vaccines
HIV
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF)
Yahoo
Wed, 07/1/15 - 10:51 pm
Gilead Sciences
HIV
R/F/TAF
FDA
HIV biotech Calimmune bags $15M to move one-time gene therapy into the clinic
Fierce Biotech
Wed, 05/27/15 - 09:59 am
HIV
gene therapy
Calimmune
Bristol-Myers Faces a Compulsory License for an AIDS Drug in Peru
WSJ Pharmalot
Thu, 05/21/15 - 12:44 pm
Bristol-Myers Squibb
AIDS
HIV
Peru
Reyataz
Hype or hope? GlaxoSmithKline bankrolls a tiny startup in search of an HIV cure
Fierce Biotech
Mon, 05/11/15 - 09:23 am
GSK
HIV
Qura Therapeutics
GlaxoSmithKline targets growth across units, scraps ViiV listing
Yahoo/Reuters
Wed, 05/6/15 - 08:53 am
GSK
ViiV
HIV
GeoVax to Seek Dual Pathway for Advancing Its HIV Preventive Vaccine
Yahoo
Tue, 04/14/15 - 10:38 am
GeoVax
HIV
vaccines
Gilead's Little Tweak Could Produce Big Revenue
Investopedia
Thu, 04/9/15 - 09:42 am
Gilead Sciences
HIV
Viread
TAF
Gilead's low-dose, high-impact HIV drug heads to the FDA
Bizjournals.com
Wed, 04/8/15 - 10:17 am
Gilead Sciences
HIV
FDA
tenofovir
emtricitabine
Study of potential HIV 'cure' wins FDA nod
Bizjournals.com
Wed, 03/4/15 - 08:16 am
FDA
HIV
Sangamo BioSciences
gene editing
Gilead Sciences: ‘HIV Succession Plan Coming Into Focus’
Barron's
Fri, 02/27/15 - 07:02 pm
HIV
Gilead Sciences
Quad

Pages